ATE.V: Phase 2b Efficacy Trial for ATB-346 Underway… – Zacks Small Cap Research

ATE.V: Phase 2b Efficacy Trial for ATB-346 Underway… Zacks Small Cap Research

04/02/2019. Download this Report (). By David Bautz, PhD. TSX:ATE.V READ THE FULL ATE.V RESEARCH REPORT Business Update Phase 2b Study of …

About The Author

error: Content is protected !!
Scroll to Top